D-0007-2026 Class II Ongoing

Recalled by AvKARE — Pulaski, TN

FDA drug recall D-0007-2026 was initiated by AvKARE on Sep 2, 2025 and is designated Class II. Reason for recall: Failed Content Uniformity Specifications The recall status is ongoing. Affected quantity: 2192 cartons.

Recall details

Product Type
Drugs
Report Date
Oct 15, 2025
Initiation Date
Sep 2, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2192 cartons

Product description

Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28

Reason for recall

Failed Content Uniformity Specifications

Distribution pattern

U.S. Nationwide

Code information

Lot # LF41138A; Exp 06/30/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0007-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0007-2026. Report a data issue: hello@regdatalab.com.